Blood Tests for Pyoderma Gangrenosum
Order a complete blood count with differential, inflammatory markers (ESR and CRP), comprehensive metabolic panel, and screen for associated systemic diseases including inflammatory bowel disease, inflammatory arthritis, and hematologic malignancies.
Essential Initial Laboratory Panel
Core Inflammatory and Metabolic Assessment
All patients with suspected or confirmed pyoderma gangrenosum require:
- Complete blood count (CBC) with differential - to assess for neutrophil dysfunction, anemia (particularly dyserythropoietic anemia if considering autoinflammatory syndromes), and hematologic abnormalities 1
- Inflammatory markers: ESR and CRP - to quantify systemic inflammation and establish baseline for monitoring treatment response 2
- Comprehensive metabolic panel - including renal function (essential before initiating immunosuppressive therapy) and liver function 1
Screening for Associated Systemic Diseases
Since PG is associated with inflammatory bowel disease in up to 30% of cases and other autoimmune conditions, targeted screening is critical 3:
For inflammatory bowel disease:
- Fecal calprotectin or colonoscopy referral if gastrointestinal symptoms present
- Consider this especially given the 0.6-2.1% prevalence of PG in ulcerative colitis patients 3
For inflammatory arthritis:
- Rheumatoid factor (RF) and anti-CCP antibodies if joint symptoms present 1
- HLA-B27 typing if axial symptoms or inflammatory back pain 1
For hematologic disorders:
- Serum protein electrophoresis (SPEP) to screen for monoclonal gammopathies 4
- Peripheral blood smear if CBC abnormalities detected
Autoimmune and Autoinflammatory Screening
When clinical features suggest broader autoimmune involvement 5:
- Autoantibody panel: ANA, anti-dsDNA, ANCA, anti-phospholipid antibodies - particularly important as these can be transiently elevated in autoinflammatory conditions 5
- If PG occurs with fever, arthritis, and acne (PAPA syndrome): Consider PSTPIP1 gene testing 5
Metabolic Bone Assessment
If considering autoinflammatory syndromes or chronic disease 1:
- Alkaline phosphatase
- Calcium, phosphate, 25-hydroxy-vitamin D
- Parathyroid hormone (PTH)
These exclude metabolic bone diseases like osteomalacia or Paget's disease that can mimic inflammatory conditions.
Infection Exclusion
Critical caveat: PG ulcers contain purulent material that is sterile on culture unless secondary infection has occurred 3. However, wound cultures are still necessary to exclude infectious mimics like ecthyma or necrotizing infections before diagnosing PG 3.
Comorbidity Screening Based on Clinical Context
Diabetes and Metabolic Syndrome
Given the 1.5-3 fold increased risk of type 2 diabetes (prevalence up to 30% in HS, which shares pathophysiology with PG) 2:
- Hemoglobin A1c or fasting glucose
- Lipid panel if metabolic syndrome suspected
Additional Context-Dependent Testing
If hidradenitis suppurativa coexists (PG prevalence 0.2-0.4% in HS, up to 20-fold increased odds) 6:
- Screen for polycystic ovarian syndrome in women with menstrual irregularities
- Consider thyroid function tests
What NOT to Order Routinely
- Genetic testing for γ-secretase mutations or single nucleotide polymorphisms - no current diagnostic role 2
- Biomarkers like IL-6, IL-17A, TNF, leukotriene A4 hydrolase - research tools only, not clinically validated 2
- Routine bone biopsy - reserved only for cases with inconclusive imaging or suspicion of malignancy/osteomyelitis 1
Algorithmic Approach
- First-line panel (all patients): CBC with differential, ESR, CRP, CMP
- Second-line based on review of systems:
- GI symptoms → IBD workup
- Joint symptoms → RF, anti-CCP, HLA-B27
- Constitutional symptoms → SPEP, autoantibody panel
- Third-line if atypical features: Genetic testing for autoinflammatory syndromes (PSTPIP1 if fever + arthritis + acne pattern) 5
Common pitfall: Misinterpreting positive wound cultures as excluding PG - remember that secondary infection can occur in genuine PG ulcers 3. The diagnosis remains clinical with supportive laboratory exclusion of mimics.